BIOCRYST PHARMACEUTICALS, INC. (BCRX) Gross margin 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
97.8%FY2025 · since FY2016: 91.3% → 97.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 97.8% | +0.5 pp |
| FY2024 | 97.3% | -1.4 pp |
| FY2023 | 98.6% | +1.0 pp |
| FY2022 | 97.6% | +2.2 pp |
| FY2021 | 95.4% | +4.1 pp |
| FY2020 | 91.3% | -1.1 pp |
| FY2019 | 92.4% | — |
| FY2017 | 95.5% | +4.2 pp |
| FY2016 | 91.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice